Skip To Main Content
Julia Bohlius on Muck Rack

Julia Bohlius

As seen in: MDPI, Biomed Central (BMC), medRxiv, eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Julia Bohlius’s profile

Articles by Julia Bohlius

Impact of the 2013 WHO guidelines for screening and treatment of cervical precancerous lesions on womens screening rates, by HIV-status, in East and Southern Africa: A regression discontinuity design analysis

|
By David Chipanta, Connie Osborne, Julia Bohlius, Ani Shakarishvilia
| medRxiv
The authors declare no competing interests. Olivia Keiser was supported by the Swiss National Science Foundation (grant no 202660). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (45) Issue with article?

Non-Specific Effects of Bacillus Calmette-Guérin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

|
By Julia Bohlius, Gerhard Trunk, Maša Davidović
| MDPI
Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
Open in Who Shared Issue with article?

Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry

|
By Tafadzwa Dhokotera, Serra Lem Asangbeh, Julia Bohlius, Elvira Singh
| eCancer Verified
Tafadzwa Dhokotera1,2,3, Serra Asangbeh2,3, Julia Bohlius3,4,5, Elvira Singh1,6, Matthias Egger5,7,8, Eliane Rohner5, Jabulani Ncayiyana6,9, Gary M Clifford10, Victor Olago1,6 and Mazvita Sengayi-Muchengeti1,6,11 1National Cancer Registry, National Health Laboratory Science, 1 Modderfontein Road, Sandringham, Johannesburg 2192, South Africa 2Graduate School for Cellular and Biomedical Sciences, University of Bern, Uni Mittelstrasse, Mittelstrasse 43, CH-3012 Bern, Switzerland 3Swiss Tropical...
Open in Who Shared Issue with article?

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

|
By Julia Bohlius, Kari Bohlke, Alejandro Lazo-Langner
| ascopubs.org
Journal of Oncology Practice
Open in Who Shared Issue with article?

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update

|
By Julia Bohlius, Kari Bohlke, Roberto Castelli, Benjamin Djulbegovic
| bloodadvances.org
Julia Bohlius, Kari Bohlke, Roberto Castelli, Benjamin Djulbegovic, Maryam B. Lustberg, Massimo Martino, Giannis Mountzios, Namrata Peswani, Laura Porter, Tiffany N.
Open in Who Shared Issue with article?

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

|
By Kari Bohlke, Benjamin Djulbegovic, Julia Bohlius, Roberto Castelli
| ascopubs.org
Use of erythropoiesis-stimulating agents (ESAs) to manage anemia raises hemoglobin (HgB) levels and reduces the need for RBC transfusions, but increases the risk of thromboembolic events.1,2 Studies have also reported decreased survival, increased mortality during active study phase, and/or an increased risk of cancer progression or recurrence with the use of ESAs in patients with cancer.3-6 The risks of ESAs prompted multiple regulatory actions by the US Food and Drug Administration (FDA)...
Open in Who Shared Issue with article?
Show More